Concurrently using rosiglitazone prevents glucosamine-induced islet β-Cell apoptosis and dysfunction

Cell Biochemistry and Function

Volumn 28, Issue 6, 2010, Pages 509-514

  Zhang, Xinxia ^a   Tong, Nanwei ^b   Li, Yao ^c  

^a CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SICHUAN UNIVERSITY   (China)

^c CHENGDU MEDICAL COLLEGE   (China)

Author keywords

Apoptosis; Diabetes; Glucosamine; Islet beta cell; Mitochondrion; Rosiglitazone

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE 3; GLUCOSAMINE; INSULIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; ROSIGLITAZONE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; INSULIN RELEASE; PANCREAS ISLET BETA CELL; PANCREAS ISLET DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL LINE, TUMOR; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION; GLUCOSAMINE; HUMANS; INSULIN-SECRETING CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; THIAZOLIDINEDIONES;

EID: 77956853914     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1684     Document Type: Article

References (20)

1. Giaccari A, Sorice G, Muscogiuri G. Glucose toxicity: The leading actor in the pathogenesis and clinical history of type 2 diabetes - mechanisms and potentials for treatment. Nutr Metab Cardiovasc Dis 2009; 19: 365-377.
2. Brunner Y, Schvartz D, Priego-Capote F, Couté Y, Sanchez JC. Glucotoxicity and pancreatic proteomics. J Proteomics 2009; 71: 576-591.
3. Issad T, Kuo M. O-GlcNAc modification of transcription factors, glucose sensing and glucotoxicity. Trends Endocrinol Metab 2008; 19: 380-389.
4. Cerasi E, Ktorza A. Anatomical and functional plasticity of pancreatic beta-cells and type 2 diabetes. Med Sci (Paris) 2007; 23: 885-894.
5. Campbell RK. Fate of the beta-cell in the pathophysiology of type 2 diabetes. J Am Pharm Assoc (2003). 2009; 49 (Suppl 1): S10-S15.
6. Newsholme P, Haber EP, Hirabara SM, et al. Diabetes associated cell stress and dysfunction: Role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol 2007; 583: 9-24.
7. Golks A, Guerini D. The O-linked N-acetylglucosamine modification in cellular signalling and the immune system. 'Protein modifications: Beyond the usual suspects' review series. EMBO Rep 2008; 9: 748-753.
8. Unalp A, Ploth DW, Colvin R, et al. Does poly-N-acetyl glucosamine patch use reduce arteriovenous fistula and graft failure rates in hemodialysis patients with end-stage renal disease? Am J Med Sci 2009; 338: 178-184.
9. Dahmer S, Schiller RM. Glucosamine. Am Fam Physician 2008; 78: 471-476.
10. Zraika S, Aston-Mourney K, Laybutt DR, et al. The influence of genetic background on the induction of oxidative stress and impaired insulin secretion in mouse islets. Diabetologia 2006; 49: 1254-1263.
11. Zraika S, Dunlop M, Proietto J, Andrikopoulos S. The hexosamine biosynthesis pathway regulates insulin secretion via protein glycosylation in mouse islets. Arch Biochem Biophys 2002; 405: 275-279.
12. Wu J, Lei MX, Xie XY, et al. Rosiglitazone inhibits high glucoseinduced apoptosis in human umbilical vein endothelial cells through the PI3K/Akt/eNOS pathway. Can J Physiol Pharmacol 2009; 87: 549-555.
13. Yasuda K, Richez C, Uccellini MB, et al. Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNAcontaining immune complexes. J Immunol 2009; 183: 3109-3117.
14. Feng BS, Zheng PY, Chen X, Liao XQ, Yang PC. Investigation of the role of cholera toxin in assisting the initiation of the antigen-specific Th2 response. Immunol Invest 2008; 37: 782-797.
15. Liu K, Paterson AJ, Chin E, Kudlow JE. Glucose stimulates protein modification by O-linked GlcNAc in pancreatic beta cells: Linkage of O-linked GlcNAc to beta cell death. Proc Natl Acad Sci U S A 2000; 97: 2820-2825.
16. Guilherme L, Kalil J, Cunningham M. Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity 2006; 39: 31-39. (Pubitemid 43878518)
17. Matsuno H, Nakamura H, Katayama K, et al. Effects of an oral administration of glucosamine-chondroitin-quercetin glucoside on the synovial fluid properties in patients with osteoarthritis and rheumatoid arthritis. Biosci Biotechnol Biochem 2009; 73: 288-292.
18. Gauthier BR, Wiederkehr A, Baquié M, et al. PDX1 deficiency causes mitochondrial dysfunction and defective insulin secretion through TFAM suppression. Cell Metab 2009; 10: 110-118.
19. Molina AJ, Wikstrom JD, Stiles L, et al. Mitochondrial networking protects beta-cells from nutrient-induced apoptosis. Diabetes 2009; 58: 2303-2315.
20. Tsukada S, Kobayashi MA, Omori S, Unoki H, Maeda S. Transcription factor AP-2beta inhibits glucose-induced insulin secretion in cultured insulin-secreting cell-line. Diabetes Res Clin Pract 2009; 85: 279-285.